In This Section
John T. Schiller, PhD

John T. Schiller, PhD

National Cancer Institute
Bethesda, Maryland

Class of 2024

For championed research that has reduced the incidence of human papillomavirus (HPV)-associated cancers through the elucidation of HPV virion assembly and infection mechanisms, determining how virus-like particle vaccine-induced antibodies prevent infection and tumorigenesis, and demonstrating that introduction of short viral protein fragments can induce anti-tumor immune responses.

*Full-length biography pending